Palatin Technologies
PTN
#9923
Rank
ยฃ29.37 M
Marketcap
ยฃ17.25
Share price
4.59%
Change (1 day)
2,267.19%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -ยฃ13.14 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ20.21 Million, an increase over its 2023 earnings that were of -ยฃ24.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ13.14 Million-35.02%
2024 -ยฃ20.21 Million-16.9%
2023 -ยฃ24.32 Million5.99%
2022 -ยฃ22.95 Million-13.7%
2021 -ยฃ26.59 Million33.25%
2020 -ยฃ19.96 Million-172.11%
2019 ยฃ27.66 M2352.33%
2018 ยฃ1.12 M-94.13%
2017 ยฃ19.22 M-154.92%
2016 -ยฃ35.01 Million3.67%
2015 -ยฃ33.77 Million878%
2014 -ยฃ3.46 Million-72.64%
2013 -ยฃ12.62 Million-33.11%
2012 -ยฃ18.87 Million77.71%
2011 -ยฃ10.62 Million
2003 -ยฃ17.98 Million29.93%
2002 -ยฃ13.84 Million36.18%
2001 -ยฃ10.16 Million
1999 -ยฃ8.44 Million6.04%
1998 -ยฃ7.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-ยฃ8.86 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.12 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ37.92 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ50.1 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.26 Million 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.30 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ41.68 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.81 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK